6:17 PM
 | 
Jan 17, 2014
 |  BC Extra  |  Company News

Keryx's ferric citrate gets Japanese approval

Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) said Japan's Ministry of Health, Labor and Welfare (MHLW) approved Riona ferric citrate to treat hyperphosphatemia in dialysis-dependent and non-dialysis-dependent patients with chronic kidney disease (CKD)....

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >